Citation 69783

GODA,Y: KIUCHI,F: SHIBUYA,M: SANKAWA,U:. (1992). INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS FROM DALBERGIA ODORIFERA.. 40(9)

Citation Details

Title	INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS FROM DALBERGIA ODORIFERA.
Authors	GODA,Y: KIUCHI,F: SHIBUYA,M: SANKAWA,U:
Year	1992
Volume	40
Issue	9

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Dalbergia odorifera (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	MISCELLANEOUS EFFECTS	MEDICINAL FOLKLORE REPORTED FOR	None	None
2	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OFCOMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	OBTUSTYRENE	None
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MUCRONUSTYRENE,ISO:	None
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONUSTYRENE,ISO:	INACTIVE
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONUSTYRENE,ISO:	ACTIVE
10	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONUSTYRENE,ISO:	ACTIVE
11	MONOAMINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONUSTYRENE,ISO:	ACTIVE
12	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDORD SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DUARTIN,(+):	None
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DUARTIN,ISO: (DL):	None
14	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	MELILOTOCARPAN C	None
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDORD SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ODORICARPAN,(-):	None
16	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	BENZOIC ACID,2-HYDROXY-3-4-DIMETHOXY: METHYL ESTER	None
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID,2-HYDROXY-3-4-DIMETHOXY: METHYL ESTER	INACTIVE
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID,2-HYDROXY-3-4-DIMETHOXY: METHYL ESTER	ACTIVE
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID,2-HYDROXY-3-4-DIMETHOXY: METHYL ESTER	ACTIVE
20	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOIC ACID,2-HYDROXY-3-4-DIMETHOXY: METHYL ESTER	ACTIVE
21	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OBTUSTYRENE,HYDROXY:	None
22	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSTYRENE,HYDROXY:	INACTIVE
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSTYRENE,HYDROXY:	ACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSTYRENE,HYDROXY:	WEAK ACTIVITY
25	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSTYRENE,HYDROXY:	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	MUCRONULATOL,(DL):	None
27	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONULATOL,(DL):	INACTIVE
28	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONULATOL,(DL):	ACTIVE
29	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONULATOL,(DL):	INACTIVE
30	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MUCRONULATOL,(DL):	ACTIVE
31	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ODORIFLAVENE	None
32	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	NISSOLIN,METHYL: (-):	None
33	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NISSOLIN,METHYL: (-):	INACTIVE
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NISSOLIN,METHYL: (-):	ACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NISSOLIN,METHYL: (-):	INACTIVE
36	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NISSOLIN,METHYL: (-):	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	MEDICARPIN,(DL):	None
38	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN,(DL):	INACTIVE
39	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN,(DL):	WEAK ACTIVITY
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN,(DL):	INACTIVE
41	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN,(DL):	INACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	VESTITOL,(DL):	None
43	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VESTITOL,(DL):	WEAK ACTIVITY
44	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VESTITOL,(DL):	ACTIVE
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VESTITOL,(DL):	WEAK ACTIVITY
46	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VESTITOL,(DL):	ACTIVE
47	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	FORMONONETIN	None
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
49	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	ACTIVE
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
51	PROSTAGLANDIN SYNTHETASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE

Citation 69783

Citation Details

Summary

Organisms and Their Experiments (1)

Dalbergia odorifera (FABACEAE)

Show SPARQL Queries (1)

Query 1